Page last updated: 2024-11-13

penicillin g sodium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID23668834
CHEMBL ID1126
CHEBI ID51765
SCHEMBL ID34218
MeSH IDM0016134

Synonyms (119)

Synonym
crystapen
AC-13436
cas-69-57-8
NCGC00017015-01
sodium penicillin ii
sodium benzylpenicillin
benzylpenicillin sodium salt
penicillin g sodium
sodium benzylpenicillinate
nsc-402815
ok 431
sodium penicillin g
benzylpenicillinic acid sodium salt
sodium benzylpenicillin g
sugracillin sodium salt
kesso-pen
benzylpenicillin sodium
novocillin
penicillin-g, monosodium salt
pen-a-brasive
penilaryn
veticillin
sodium penicillin
american penicillin
69-57-8
penicillin g sodium salt
penicillin g sodium (tn)
penicillin g sodium (usp)
D05408
penicillin g, sodium
penicillin g sodium, crystalline
nsc 402815
sodium (2s-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2s-(2alpha,5alpha,6beta))-, monosodium salt
sodium benzylpenicyllinate
einecs 200-710-2
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, monosodium salt
sodium 6-(phenylacetamido)penicillanate
monosodium (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
pencillin g sodium
mycofarm
monosodium benzylpenicillin
penicillin g sodium salt, powder, bioreagent, suitable for cell culture
penicillin g sodium salt, ~1650 u/mg
CHEBI:51765 ,
sodium 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylate
P1770
ethacillin
benzylpenicillinum natricum
benzyl penicillin sodium
penicillin sodium
penicillinum
e706
monocillin
sodium benzylpenicillinoate
CHEMBL1126
HMS1571G18
HMS2098G18
S4160
AKOS015961217
unii-ys5ly7jf4n
penicillin g sodium [usp]
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2s,5r,6r)-, monosodium salt
ys5ly7jf4n ,
penicillinum [hpus]
benzylpenicillinum natricum [who-ip latin]
penicillin g sodium [usp-rs]
penicillin g sodium salt [mi]
penicillin g sodium [orange book]
benzylpenicillin sodium [mart.]
sodium (2s-(2.alpha.,5.alpha.,6.beta.))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
penicillin g sodium [vandf]
benzylpenicillin sodium [ep impurity]
penicillin g sodium [usp monograph]
monosodium (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
benzylpenicillin sodium [who-ip]
benzylpenicillin sodium [who-dd]
benzylpenicillin sodium [ep monograph]
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2s-(2.alpha.,5.alpha.,6.beta.))-, monosodium salt
CCG-221078
SCHEMBL34218
P-1200
pencillin g sodium salt, antibiotic for culture media use only
FCPVYOBCFFNJFS-LQDWTQKMSA-M
F0001-2583
sodium (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
tetrabromobisphenoladiglycidylether
benzyl penicillin potassium
HY-B1463
CS-7971
mfcd00069666
DTXSID6040581 ,
benzylpenicillin sodium, european pharmacopoeia (ep) reference standard
penicillin g sodium salt, 96.0-102.0%
penicillin g sodium, united states pharmacopeia (usp) reference standard
C76205
HMS3715G18
SW197252-3
69-57-8 (sodium)
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenylacetyl)amino)- (2s,5r,6r)-, sodium salt (1:1)
Q27122736
4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2s,5r,6r)-, sodium salt(1:1)
EN300-25914569
AS-80974
penicillin g sodium salt, cell culture grade
3,3-dimethyl-7-oxo-6-(2-phenyl=acetamido)-4-thia-1-azabicyclo(3.2.0)heptane-
nalpen g
benzylpenicillin sodium (mart.)
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2s-(2alpha,5alpha,6.beta)).-, monosodium salt
sodium benzyl penicillin
4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-,(2s-(2alpha,5alpha,6beta))-, monosodium salt
penicillin-g, sodium
penicillin g sodium (usp-rs)
benzylpenicillin sodium (ep impurity)
penicillin g sodium (usp monograph)
dtxcid4020581
penicillin g, sodium salt
benzylpenicillin sodium (ep monograph)
2-carboxylic acid, monosodium salt

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chymotrypsinogen ABos taurus (cattle)IC50 (µMol)5.40000.98004.05607.2000AID1510602; AID1510604
Beta-lactamaseEnterobacter cloacaeIC50 (µMol)5.40000.10001.87457.7000AID1510602; AID1510604
Solute carrier family 22 member 20Mus musculus (house mouse)Ki454.54401.10006.67899.1201AID360149
Solute carrier family 22 member 6Mus musculus (house mouse)Ki329.56550.40745.02179.4000AID360150
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1)

Processvia Protein(s)Taxonomy
digestionChymotrypsinogen ABos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
protein bindingChymotrypsinogen ABos taurus (cattle)
serpin family protein bindingChymotrypsinogen ABos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
extracellular regionChymotrypsinogen ABos taurus (cattle)
serine protease inhibitor complexChymotrypsinogen ABos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (64)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1435413Anti-bacterial activity against Escherichia coli ATCC 11303 measured after 24 hrs by microtiter broth dilution method2017European journal of medicinal chemistry, Jan-27, Volume: 126Design, synthesis and antimicrobial evaluation of novel benzoxazole derivatives.
AID1138525Antibacterial activity against Streptococcus pneumoniae assessed as growth inhibition by agar dilution assay2014Journal of medicinal chemistry, May-08, Volume: 57, Issue:9
Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.
AID613255Antibacterial activity against Escherichia coli ATCC 11303 after 24 hrs by NCCLS M7-A6 broth dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design, synthesis and antimicrobial activity of chiral 2-(substituted-hydroxyl)-3-(benzo[d]oxazol-5-yl)propanoic acid derivatives.
AID608254Antibacterial activity against 1 x 10'4 cfu/mL Staphylococcus aureus ATCC 29213 after 24 hrs by NCCLS M7-A6 microtiter broth dilution method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Synthesis and antimicrobial evaluation of new benzofuran derivatives.
AID71052Compound was tested for photoinhibition of Escherichia coli (CIP 548T); No data1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
Nitroglycosylated meso-arylporphyrins as photoinhibitors of gram positive bacteria.
AID1251777Antimicrobial activity against Escherichia coli ATCC 8739 by MTT assay2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
AID1678768Antibacterial activity against Staphylococcus aureus ATCC 43300 using Cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID608336Antibacterial activity against 1 x 10'4 cfu/mL methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by NCCLS M7-A6 microtiter broth dilution method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Synthesis and antimicrobial evaluation of new benzofuran derivatives.
AID1678766Antibacterial activity against Escherichia coli ATCC 25922 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1678761Antibacterial activity against Acinetobacter baumannii ATCC 19606 using cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1399733Antibacterial activity against Staphylococcus aureus at 2 mg/ml after 4 to 10 hrs by filter paper dispersion method2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID1678764Antibacterial activity against Pseudomonas aeruginosa ATCC 27893 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID1138524Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as growth inhibition by agar dilution assay2014Journal of medicinal chemistry, May-08, Volume: 57, Issue:9
Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.
AID1399736Antibacterial activity against Erwinia caratovora at 2 mg/ml after 4 to 10 hrs by filter paper dispersion method2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID1678763Antibacterial activity against Pseudomonas aeruginosa ATCC 27893 using cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1678769Antibacterial activity against Staphylococcus aureus ATCC 43300 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1678762Antibacterial activity against Acinetobacter baumannii ATCC 19606 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1251779Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by MTT assay2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
AID83651Minimum inhibitory concentration required for primary screening against in-house strain of Haemophilus influenzae tested in vitro; ND- Not determined2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Peptide deformylase inhibitors with activity against respiratory tract pathogens.
AID360150Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID608337Antibacterial activity against 1 x 10'4 cfu/mL Bacillus subtilis ATCC 33712 after 24 hrs by NCCLS M7-A6 microtiter broth dilution method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Synthesis and antimicrobial evaluation of new benzofuran derivatives.
AID667376Antibacterial activity against Escherichia coli ATCC 11303 after 24 hrs by microtiter broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antimicrobial evaluation of 3-methanone-6-substituted-benzofuran derivatives.
AID613260Antifungal activity against Candida albicans ATCC 10231 after 24 hrs by NCCLS M38-P broth dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design, synthesis and antimicrobial activity of chiral 2-(substituted-hydroxyl)-3-(benzo[d]oxazol-5-yl)propanoic acid derivatives.
AID1435416Anti-bacterial activity against Bacillus subtilis ATCC 33712 measured after 24 hrs by microtiter broth dilution method2017European journal of medicinal chemistry, Jan-27, Volume: 126Design, synthesis and antimicrobial evaluation of novel benzoxazole derivatives.
AID1678780Antibacterial activity against Enterococcus faecalis ATCC 51299 using Cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID613256Antibacterial activity against Staphylococcus aureus ATCC 10832 after 24 hrs by NCCLS M7-A6 broth dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design, synthesis and antimicrobial activity of chiral 2-(substituted-hydroxyl)-3-(benzo[d]oxazol-5-yl)propanoic acid derivatives.
AID366997Antimicrobial activity against Staphylococcus aureus ATCC 6538 at 0.019 uM after 17 hrs by disk diffusion assay2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Synthesis and preliminary antibacterial evaluation of simplified thiomarinol analogs.
AID1678765Antibacterial activity against Escherichia coli ATCC 25922 using cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID667375Antibacterial activity against Bacillus subtilis ATCC 33712 after 24 hrs by microtiter broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antimicrobial evaluation of 3-methanone-6-substituted-benzofuran derivatives.
AID360149Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID1510602Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID667374Antibacterial activity against Pseudomonas aeruginosa ATCC 49189 after 24 hrs by microtiter broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antimicrobial evaluation of 3-methanone-6-substituted-benzofuran derivatives.
AID208762Minimum inhibitory concentration required for primary screening against in-house strain of Streptococcus pneumoniae tested in vitro; Range-0.008-22004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Peptide deformylase inhibitors with activity against respiratory tract pathogens.
AID206394Compound was tested for photoinhibition of Staphylococcus aureus(CIP 53156); Sensitive1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
Nitroglycosylated meso-arylporphyrins as photoinhibitors of gram positive bacteria.
AID1678760Antibacterial activity against Klebsiella pneumoniae ATCC 700603 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID360151Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID667373Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by microtiter broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antimicrobial evaluation of 3-methanone-6-substituted-benzofuran derivatives.
AID613257Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by NCCLS M7-A6 broth dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design, synthesis and antimicrobial activity of chiral 2-(substituted-hydroxyl)-3-(benzo[d]oxazol-5-yl)propanoic acid derivatives.
AID1753048Antibacterial activity against Staphylococcus aureus subsp. aureus ATCC 29213 assessed as bacterial growth inhibition incubated for 24 hrs by Reed-Muench method
AID1399735Antibacterial activity against Ralstonia solanacearum at 2 mg/ml after 4 to 10 hrs by filter paper dispersion method2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID1510614Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins in presence of 0.1 to 0.5 M GdnHCl by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1435414Anti-bacterial activity against Staphylococcus aureus ATCC 10832 measured after 24 hrs by microtiter broth dilution method2017European journal of medicinal chemistry, Jan-27, Volume: 126Design, synthesis and antimicrobial evaluation of novel benzoxazole derivatives.
AID1510608Inhibition of Enterobacter cloacae beta-lactamase treated with enzyme for 10 mins following enzyme incubation with 0.7 to 2.1 M DMSO for 5 mins followed by nitrocefin substrate challenge and measured for 5 mins by DMSO perturbation assay2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID613258Antibacterial activity against Bacillus subtilis ATCC 33712 after 24 hrs by NCCLS M7-A6 broth dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design, synthesis and antimicrobial activity of chiral 2-(substituted-hydroxyl)-3-(benzo[d]oxazol-5-yl)propanoic acid derivatives.
AID366998Antimicrobial activity against Staphylococcus aureus ATCC 25923 at 0.019 uM after 17 hrs by disk diffusion assay2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Synthesis and preliminary antibacterial evaluation of simplified thiomarinol analogs.
AID1678767Antibacterial activity against Enterococcus faecalis ATCC 51299 using DMSO as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1399734Antibacterial activity against Bacillus cereus at 2 mg/ml after 4 to 10 hrs by filter paper dispersion method2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID1510613Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins in presence of 0.1 to 0.5 M DMA by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1251778Antimicrobial activity against Staphylococcus aureus ATCC 6538 by MTT assay2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
AID667372Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by microtiter broth dilution method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antimicrobial evaluation of 3-methanone-6-substituted-benzofuran derivatives.
AID1510604Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins in presence of Triton X-100 by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1435411Anti-fungal activity against Candida albicans ATCC 10231 measured after 24 hrs by microtiter broth dilution method2017European journal of medicinal chemistry, Jan-27, Volume: 126Design, synthesis and antimicrobial evaluation of novel benzoxazole derivatives.
AID1678759Antibacterial activity against Klebsiella pneumoniae ATCC 700603 using cyrene as solvent by broth microdilution method2020RSC medicinal chemistry, Jan-01, Volume: 11, Issue:1
Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.
AID1478700Antibacterial activity against Staphylococcus aureus ATCC 6538 after 4 to 5 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
AID1399732Antibacterial activity against Bacillus thuringiensis at 2 mg/ml after 4 to 10 hrs by filter paper dispersion method2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID125105Minimum inhibitory concentration required for primary screening against in-house strain of Moraxella catarrhalis tested in vitro; ND- Not determined2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Peptide deformylase inhibitors with activity against respiratory tract pathogens.
AID1435415Anti-bacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 measured after 24 hrs by microtiter broth dilution method2017European journal of medicinal chemistry, Jan-27, Volume: 126Design, synthesis and antimicrobial evaluation of novel benzoxazole derivatives.
AID608253Antibacterial activity against 1 x 10'4 cfu/mL Escherichia coli ATCC 11303 after 24 hrs by NCCLS M7-A6 microtiter broth dilution method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Synthesis and antimicrobial evaluation of new benzofuran derivatives.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.76)18.2507
2000's3 (14.29)29.6817
2010's14 (66.67)24.3611
2020's3 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.61 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index5.25 (4.65)
Search Engine Demand Index72.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]